SARS-CoV-2 Neutralising Antibody Test
An accurate measure of vaccine effectiveness to Wuhan and Delta Variants
Accurately estimate immunity and vaccine effectiveness
The Randox SARS-CoV-2 Surrogate Virus Neutralisation Assays detect antibodies that block interaction of the spike protein receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2)
Deployment of a neutralising antibody test is of significant interest to clinical, academic, pharma and government interest. There is an urgent need for tests of this kind to provide an accurate estimate of immunity, monitor vaccine effectiveness and the frequency of post vaccine breakthrough infections with variants of concern. Two tests are currently available utilising patented biochip technology to detect neutralising antibodies to the Wuhan and Delta SARS-CoV-2 variants. Recent studies indicate that the delta variant is capable of re-infection even in fully vaccinated individuals and that a significant proportion of fully vaccinated individuals with breakthrough infections are capable of transmitting the virus to others.
|Wild Type SARS-CoV-2 Surrogate Virus Neutralisation Assay||EV4454|
|Delta SARS-CoV-2 Surrogate Virus Neutralisation Assay||EV4477|
Specificty of 100% and sensitivity of 98% compared ro coventional virus neutralisation tests
Semi-automated solution suitable for medium to high throughput testing
Direct sample addition to biochip well. No off-board sample incubation required
Results available in 1.5 hours without the need for biosafety level 3 cabinet
Limited sample volume requirements
Comprehensive immunoassay and molecular test menu available
Randox Clinical Laboratory Service (RCLS)
RCLS specialise in offering an esoteric biomarker testing service, utilising the experience and knowledge Randox has built over 40 years of producing high quality in vitro diagnostics.
RCLS strive to provide a clinical laboratory testing service to meet the time sensitive, bespoke requirements of research and clinical trial projects globally.
Accredited laboratory service
Cost effective solution
Offers greater flexibility
Want to know more?
Contact us or visit our COVID-19 Monitoring & Management page